UK asks regulator to assess Pfizer vaccine for suitability
LONDON (Reuters) - Britain has formally asked its medical regulator, the MHRA, to assess the vaccine being produced by Pfizer Inc and its German partner BioNTech, health minister Matt Hancock said on Friday. Pfizer said it would apply to U.S. health regulators on Friday for emergency use authorization (EUA) of its COVID-19 vaccine, the first such application in a major step toward providing protection against the new coronavirus.
LONDON (Reuters) - Britain has formally asked its medical regulator, the MHRA, to assess the vaccine being produced by Pfizer Inc and its German partner BioNTech, health minister Matt Hancock said on Friday.
Pfizer said it would apply to U.S. health regulators on Friday for emergency use authorization (EUA) of its COVID-19 vaccine, the first such application in a major step toward providing protection against the new coronavirus.
Related Articles
"Here in the UK, the first step for authorising a vaccine is for the government formally to ask the independent regulator..., the MHRA, to assess its suitability," Hancock told reporters.
"I can confirm that the government has formally asked the MHRA to assess the Pfizer BioNTech vaccine for its suitability for authorisation."
(Reporting by Kate Holton and Elizabeth Piper; editing by Stephen Addison)
This story has not been edited by Firstpost staff and is generated by auto-feed.
also read
South Korean woman linked to scandal to be extradited from Denmark - prosecutor | Reuters
COPENHAGEN A South Korean woman wanted for questioning in connection with the scandal that brought down president Park Geun-hye has withdrawn her appeal against extradition from Denmark, the Danish state prosecutor said on Wednesday.
Pope asks Trump to be peacemaker, gives him environmental letter | Reuters
By Philip Pullella and Steve Holland | VATICAN CITY VATICAN CITY Pope Francis urged U.S.
